Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177) [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating once-daily mometasone furoate dry-powder inhaler for asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mometasone Furoate DPI (mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 4 | Status: COMPLETED